@whytee @DocMcstuffins
I distinctly recall SI saying in one webcast a few years ago MSB would be willing to run a RCT in high risk adults against something approved and therefore Ruxolitinib if that's what the FDA required.
I can't find the link now but prior to this (at least a year), I also distinctly recall an interview with KOL Dr. Susan Prockop saying that after her center's experience of treating 3 patients with Rux (She was very specific about the effects) they wouldn't be participating in a clinical trial.
Why would she say this unless she'd been asked?
I'd be grateful if you could both answer the following questions "yes" or "no"
1. Is it a fact that Dr Prockop was never asked to participate in a RCT in Ryoncil?
2. Is it your opinion that if a randomised controlled study in adults did go ahead and showed no efficacy (unlikely IMO), that would be proof it wasn't effective in children either?
@whytee @DocMcstuffinsI distinctly recall SI saying in one...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.020(1.91%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.07 | $1.04 | $4.010M | 3.797M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 67587 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 45960 | 7 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.07 |
Change
0.020 ( 2.55 %) |
||||
| Open | High | Low | Volume | ||
| $1.04 | $1.07 | $1.04 | 699949 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| MSB (ASX) Chart |